StockData
Viatris Inc logo

Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)

Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%

Viatris price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Viatris's price to sales ratio was 0.9× on Jan 31, 2025, against 0.9× a year earlier. Over the last 5 years it ranged from 0.0× to 1.0×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20250.9×−0.1
2024Dec 31, 20241.0×+0.1
2023Dec 29, 20230.8×+0.0
2022Dec 30, 20220.8×−0.1
2021Dec 31, 20210.9×+0.9
2020Dec 31, 20200.0×−0.9
2019Dec 31, 20190.9×–

More Viatris figures

See a number that looks wrong?